256 related articles for article (PubMed ID: 18190253)
1. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
[TBL] [Abstract][Full Text] [Related]
2. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
3. A recombinant envelope protein vaccine against West Nile virus.
Ledizet M; Kar K; Foellmer HG; Wang T; Bushmich SL; Anderson JF; Fikrig E; Koski RA
Vaccine; 2005 Jun; 23(30):3915-24. PubMed ID: 15917113
[TBL] [Abstract][Full Text] [Related]
4. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
[TBL] [Abstract][Full Text] [Related]
5. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
6. West Nile virus envelope protein: role in diagnosis and immunity.
Wang T; Anderson JF; Magnarelli LA; Bushmich S; Wong S; Koski RA; Fikrig E
Ann N Y Acad Sci; 2001 Dec; 951():325-7. PubMed ID: 11797789
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
Li L; Barrett AD; Beasley DW
Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
[TBL] [Abstract][Full Text] [Related]
8. Antiviral peptides targeting the west nile virus envelope protein.
Bai F; Town T; Pradhan D; Cox J; Ashish ; Ledizet M; Anderson JF; Flavell RA; Krueger JK; Koski RA; Fikrig E
J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
[TBL] [Abstract][Full Text] [Related]
9. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
Alonso-Padilla J; de Oya NJ; Blázquez AB; Escribano-Romero E; Escribano JM; Saiz JC
Vaccine; 2011 Feb; 29(9):1830-5. PubMed ID: 21211580
[TBL] [Abstract][Full Text] [Related]
10. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
[TBL] [Abstract][Full Text] [Related]
12. [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Loktev VB
Mol Biol (Mosk); 2005; 39(5):813-22. PubMed ID: 16240715
[TBL] [Abstract][Full Text] [Related]
13. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
14. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
[TBL] [Abstract][Full Text] [Related]
15. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
[TBL] [Abstract][Full Text] [Related]
16. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response.
Anwar A; Chandrasekaran A; Ng ML; Marques E; August JT
Virology; 2005 Feb; 332(1):66-77. PubMed ID: 15661141
[TBL] [Abstract][Full Text] [Related]
17. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
Davis BS; Chang GJ; Cropp B; Roehrig JT; Martin DA; Mitchell CJ; Bowen R; Bunning ML
J Virol; 2001 May; 75(9):4040-7. PubMed ID: 11287553
[TBL] [Abstract][Full Text] [Related]
18. Expression of recombinant West Nile virus prM protein fused to an affinity tag for use as a diagnostic antigen.
Setoh YX; Hobson-Peters J; Prow NA; Young PR; Hall RA
J Virol Methods; 2011 Jul; 175(1):20-7. PubMed ID: 21545809
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
[TBL] [Abstract][Full Text] [Related]
20. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]